Female VC Lab Barbara Bickham

Nicole Valentine is the FinTech Director of the Center for Financial Markets at the Milken Institute with over a decade of financial services, international Mergers & Acquisitions, technology and innovation experience. She leads the FinTech Program with a focus on access to capital, financial inclusion, compliance and transparency.

Michael Phillips is a trailblazer in the realm of social entrepreneurship and impact, devoting his life to the relentless pursuit of empowering individuals for positive change. Serving as the Chief Operating Officer at T.D. Jakes Enterprises, he spearheads innovative initiatives across Content Creation, Cultural Change, Community Development, and Capital Investments.

Alice Pomponio is Vice President of Innovation and Impact Investing at American Cancer Society and Managing Director of BrightEdge —ACS’s mission-driven venture capital and impact investment arm. She’s an impact investor, social innovation entrepreneur, and patient advocate with extensive experience in life sciences and business and passion for health equity.

Seasoned entrepreneur and resource mobilizer for positive social and environmental change.

As CEO of the Investor Leadership Network Secretariat since 2020, Amy Hepburn is charged with designing and delivering the long-term strategy of the ILN and representing the Network in collaboration with global stakeholders. Amy is a recognized impact investing expert and social entrepreneur with deep expertise on gender lens social investments and the care of children in crises. In this capacity, she has spent 20 years driving social change globally in the private, non-profit, and public sectors through the creation of unique public/private partnerships and investing for high impact social returns.

Genia Xasis is the CEO & Co-founder of Berkana.VC, a global community aimed at enhancing gender diversity in VC and tech. She assists seed and Series A companies with raising capital in MENA and is an angel investor focusing on pre-seed, female-led companies with an emphasis on impact and AI. Holds a PhD in Biochemistry.